Editorial Board — Medscape Nephrology

Board Members

 

Board Member Details

Rajiv Agarwal, MD
Rajiv Agarwal, MD

Professor of Medicine, Indiana University School of Medicine, Indianapolis, Indiana

Rajiv Agarwal, MD, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: AstraZeneca; Ironwood Pharmaceuticals; Akebia; Bayer; Janssen; Glaxo Smith Kline; Relypsa; Sanofi; Genzyme; Boehringer Ingelheim; BirdRock Bio; Celgene; Daiichi Sanyko, Inc.; Eli Lilly; Reata; Takeda Pharmaceuticals; ZS Pharma
Received income in an amount equal to or greater than $250 from: AstraZeneca; Ironwood Pharmaceuticals; Akebia; Bayer; Janssen; Glaxo Smith Kline; Relypsa; Sanofi; Genzyme; Boehringer Ingelheim; BirdRock Bio; Celgene; Daiichi Sanyko, Inc.; Eli Lilly; Reata; Takeda Pharmaceuticals; ZS Pharma
Serve(d) as an author for: UpToDate
Serve(d) as an editor for: American Journal of Nephrology; Nephrology Dialysis and Transplantation

Donal J. O'Donoghue, MBChB, FRCP
Donal O'Donoghue, MB, ChB

Professor, Manchester University Medical School; Medical Director, Citylabs, Manchester, England

Donal J. O'Donoghue, MBChB, FRCP, has disclosed no relevant financial relationship.

Richard A. Sherman, MD
Richard A. Sherman, MD

Professor Emeritus, Robert Wood Johnson Medical School, New Brunswick, New Jersey

Richard A. Sherman, MD, has disclosed no relevant financial relationships.

Matthew R. Weir, MD
Matthew R. Weir, MD

Professor of Medicine; Director, Division of Nephrology, University of Maryland School of Medicine, Baltimore, Maryland

Matthew R. Weir, MD, has disclosed the following relevant financial relationships:
Serve(d) as an advisory or consultant for: MSD; Boehringer Ingelheim; AztraZeneca; Relypsa; Vifor; Boston Scientific; AbbVie; Janssen; Bayer; Reata